Stocks / NASDAQ / NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

Our Opinion

NeuBase Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“As part of the SKS acquisition, the Company acquired the exclusive rights to an animal model for dry-AMD whereby mice are immunized with a carboxyethylpyrrole (“CEP”) which is bound to mouse serum albumin (“MSA”) as well as the rights to produce and use CEP for research, clinical, and commercial applications.” (Page 15) Read the full document

Company Description

Company Website: https://www.neubasetherapeutics.com